The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Complement Drug Market Research Report 2025

Global Complement Drug Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1724584

No of Pages : 111

Ask Your Query
Synopsis
Highlights
The global Complement Drug market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Complement Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Complement Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Complement Drug in Blood Disease is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Complement Drug include Novartis AG, Alexion Pharmaceuticals, ChemoCentryx, Roche, Apellis, Regeneron, Amgen, Alnylam and UCB, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Peptides, which accounted for % of the global market of Complement Drug in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Complement Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complement Drug.
The Complement Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Complement Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Complement Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Novartis AG
Alexion Pharmaceuticals
ChemoCentryx
Roche
Apellis
Regeneron
Amgen
Alnylam
UCB
InflaRx
ChemoCentryx
Innate Pharma
Ionis Pharmaceuticals
Avant Immunotherapeutics
Pfizer
Sanofi
Omeros
GenMab
Akari Therapeutics
AbbVie
Product Type Insights
Global markets are presented by Complement Drug type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Complement Drug are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Complement Drug segment by Type
Peptides
Antibodies
Others
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Complement Drug market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Complement Drug market.
Complement Drug Segment by Application
Blood Disease
Kidney Disease
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Complement Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Complement Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Complement Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Complement Drug industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Complement Drug.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Complement Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Complement Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Peptides
1.2.3 Antibodies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Complement Drug Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Blood Disease
1.3.3 Kidney Disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Complement Drug Market Perspective (2017-2028)
2.2 Complement Drug Growth Trends by Region
2.2.1 Complement Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Complement Drug Historic Market Size by Region (2017-2022)
2.2.3 Complement Drug Forecasted Market Size by Region (2023-2028)
2.3 Complement Drug Market Dynamics
2.3.1 Complement Drug Industry Trends
2.3.2 Complement Drug Market Drivers
2.3.3 Complement Drug Market Challenges
2.3.4 Complement Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Complement Drug Players by Revenue
3.1.1 Global Top Complement Drug Players by Revenue (2017-2022)
3.1.2 Global Complement Drug Revenue Market Share by Players (2017-2022)
3.2 Global Complement Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Complement Drug Revenue
3.4 Global Complement Drug Market Concentration Ratio
3.4.1 Global Complement Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Complement Drug Revenue in 2021
3.5 Complement Drug Key Players Head office and Area Served
3.6 Key Players Complement Drug Product Solution and Service
3.7 Date of Enter into Complement Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Complement Drug Breakdown Data by Type
4.1 Global Complement Drug Historic Market Size by Type (2017-2022)
4.2 Global Complement Drug Forecasted Market Size by Type (2023-2028)
5 Complement Drug Breakdown Data by Application
5.1 Global Complement Drug Historic Market Size by Application (2017-2022)
5.2 Global Complement Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Complement Drug Market Size (2017-2028)
6.2 North America Complement Drug Market Size by Country (2017-2022)
6.3 North America Complement Drug Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Complement Drug Market Size (2017-2028)
7.2 Europe Complement Drug Market Size by Country (2017-2022)
7.3 Europe Complement Drug Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Complement Drug Market Size (2017-2028)
8.2 Asia-Pacific Complement Drug Market Size by Country (2017-2022)
8.3 Asia-Pacific Complement Drug Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Complement Drug Market Size (2017-2028)
9.2 Latin America Complement Drug Market Size by Country (2017-2022)
9.3 Latin America Complement Drug Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Complement Drug Market Size (2017-2028)
10.2 Middle East & Africa Complement Drug Market Size by Country (2017-2022)
10.3 Middle East & Africa Complement Drug Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Complement Drug Introduction
11.1.4 Novartis AG Revenue in Complement Drug Business (2017-2022)
11.1.5 Novartis AG Recent Development
11.2 Alexion Pharmaceuticals
11.2.1 Alexion Pharmaceuticals Company Detail
11.2.2 Alexion Pharmaceuticals Business Overview
11.2.3 Alexion Pharmaceuticals Complement Drug Introduction
11.2.4 Alexion Pharmaceuticals Revenue in Complement Drug Business (2017-2022)
11.2.5 Alexion Pharmaceuticals Recent Development
11.3 ChemoCentryx
11.3.1 ChemoCentryx Company Detail
11.3.2 ChemoCentryx Business Overview
11.3.3 ChemoCentryx Complement Drug Introduction
11.3.4 ChemoCentryx Revenue in Complement Drug Business (2017-2022)
11.3.5 ChemoCentryx Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Complement Drug Introduction
11.4.4 Roche Revenue in Complement Drug Business (2017-2022)
11.4.5 Roche Recent Development
11.5 Apellis
11.5.1 Apellis Company Detail
11.5.2 Apellis Business Overview
11.5.3 Apellis Complement Drug Introduction
11.5.4 Apellis Revenue in Complement Drug Business (2017-2022)
11.5.5 Apellis Recent Development
11.6 Regeneron
11.6.1 Regeneron Company Detail
11.6.2 Regeneron Business Overview
11.6.3 Regeneron Complement Drug Introduction
11.6.4 Regeneron Revenue in Complement Drug Business (2017-2022)
11.6.5 Regeneron Recent Development
11.7 Amgen
11.7.1 Amgen Company Detail
11.7.2 Amgen Business Overview
11.7.3 Amgen Complement Drug Introduction
11.7.4 Amgen Revenue in Complement Drug Business (2017-2022)
11.7.5 Amgen Recent Development
11.8 Alnylam
11.8.1 Alnylam Company Detail
11.8.2 Alnylam Business Overview
11.8.3 Alnylam Complement Drug Introduction
11.8.4 Alnylam Revenue in Complement Drug Business (2017-2022)
11.8.5 Alnylam Recent Development
11.9 UCB
11.9.1 UCB Company Detail
11.9.2 UCB Business Overview
11.9.3 UCB Complement Drug Introduction
11.9.4 UCB Revenue in Complement Drug Business (2017-2022)
11.9.5 UCB Recent Development
11.10 InflaRx
11.10.1 InflaRx Company Detail
11.10.2 InflaRx Business Overview
11.10.3 InflaRx Complement Drug Introduction
11.10.4 InflaRx Revenue in Complement Drug Business (2017-2022)
11.10.5 InflaRx Recent Development
11.11 ChemoCentryx
11.11.1 ChemoCentryx Company Detail
11.11.2 ChemoCentryx Business Overview
11.11.3 ChemoCentryx Complement Drug Introduction
11.11.4 ChemoCentryx Revenue in Complement Drug Business (2017-2022)
11.11.5 ChemoCentryx Recent Development
11.12 Innate Pharma
11.12.1 Innate Pharma Company Detail
11.12.2 Innate Pharma Business Overview
11.12.3 Innate Pharma Complement Drug Introduction
11.12.4 Innate Pharma Revenue in Complement Drug Business (2017-2022)
11.12.5 Innate Pharma Recent Development
11.13 Ionis Pharmaceuticals
11.13.1 Ionis Pharmaceuticals Company Detail
11.13.2 Ionis Pharmaceuticals Business Overview
11.13.3 Ionis Pharmaceuticals Complement Drug Introduction
11.13.4 Ionis Pharmaceuticals Revenue in Complement Drug Business (2017-2022)
11.13.5 Ionis Pharmaceuticals Recent Development
11.14 Avant Immunotherapeutics
11.14.1 Avant Immunotherapeutics Company Detail
11.14.2 Avant Immunotherapeutics Business Overview
11.14.3 Avant Immunotherapeutics Complement Drug Introduction
11.14.4 Avant Immunotherapeutics Revenue in Complement Drug Business (2017-2022)
11.14.5 Avant Immunotherapeutics Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Detail
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Complement Drug Introduction
11.15.4 Pfizer Revenue in Complement Drug Business (2017-2022)
11.15.5 Pfizer Recent Development
11.16 Sanofi
11.16.1 Sanofi Company Detail
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Complement Drug Introduction
11.16.4 Sanofi Revenue in Complement Drug Business (2017-2022)
11.16.5 Sanofi Recent Development
11.17 Omeros
11.17.1 Omeros Company Detail
11.17.2 Omeros Business Overview
11.17.3 Omeros Complement Drug Introduction
11.17.4 Omeros Revenue in Complement Drug Business (2017-2022)
11.17.5 Omeros Recent Development
11.18 GenMab
11.18.1 GenMab Company Detail
11.18.2 GenMab Business Overview
11.18.3 GenMab Complement Drug Introduction
11.18.4 GenMab Revenue in Complement Drug Business (2017-2022)
11.18.5 GenMab Recent Development
11.19 Akari Therapeutics
11.19.1 Akari Therapeutics Company Detail
11.19.2 Akari Therapeutics Business Overview
11.19.3 Akari Therapeutics Complement Drug Introduction
11.19.4 Akari Therapeutics Revenue in Complement Drug Business (2017-2022)
11.19.5 Akari Therapeutics Recent Development
11.20 AbbVie
11.20.1 AbbVie Company Detail
11.20.2 AbbVie Business Overview
11.20.3 AbbVie Complement Drug Introduction
11.20.4 AbbVie Revenue in Complement Drug Business (2017-2022)
11.20.5 AbbVie Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Complement Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Peptides
Table 3. Key Players of Antibodies
Table 4. Key Players of Others
Table 5. Global Complement Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Complement Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Complement Drug Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Complement Drug Market Share by Region (2017-2022)
Table 9. Global Complement Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Complement Drug Market Share by Region (2023-2028)
Table 11. Complement Drug Market Trends
Table 12. Complement Drug Market Drivers
Table 13. Complement Drug Market Challenges
Table 14. Complement Drug Market Restraints
Table 15. Global Complement Drug Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Complement Drug Market Share by Players (2017-2022)
Table 17. Global Top Complement Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2021)
Table 18. Ranking of Global Top Complement Drug Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Complement Drug Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Complement Drug Product Solution and Service
Table 22. Date of Enter into Complement Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Complement Drug Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Complement Drug Revenue Market Share by Type (2017-2022)
Table 26. Global Complement Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Complement Drug Revenue Market Share by Type (2023-2028)
Table 28. Global Complement Drug Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Complement Drug Revenue Market Share by Application (2017-2022)
Table 30. Global Complement Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Complement Drug Revenue Market Share by Application (2023-2028)
Table 32. North America Complement Drug Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Complement Drug Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Complement Drug Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Complement Drug Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Complement Drug Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Complement Drug Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Complement Drug Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Complement Drug Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Complement Drug Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Complement Drug Market Size by Country (2023-2028) & (US$ Million)
Table 42. Novartis AG Company Detail
Table 43. Novartis AG Business Overview
Table 44. Novartis AG Complement Drug Product
Table 45. Novartis AG Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 46. Novartis AG Recent Development
Table 47. Alexion Pharmaceuticals Company Detail
Table 48. Alexion Pharmaceuticals Business Overview
Table 49. Alexion Pharmaceuticals Complement Drug Product
Table 50. Alexion Pharmaceuticals Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 51. Alexion Pharmaceuticals Recent Development
Table 52. ChemoCentryx Company Detail
Table 53. ChemoCentryx Business Overview
Table 54. ChemoCentryx Complement Drug Product
Table 55. ChemoCentryx Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 56. ChemoCentryx Recent Development
Table 57. Roche Company Detail
Table 58. Roche Business Overview
Table 59. Roche Complement Drug Product
Table 60. Roche Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 61. Roche Recent Development
Table 62. Apellis Company Detail
Table 63. Apellis Business Overview
Table 64. Apellis Complement Drug Product
Table 65. Apellis Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 66. Apellis Recent Development
Table 67. Regeneron Company Detail
Table 68. Regeneron Business Overview
Table 69. Regeneron Complement Drug Product
Table 70. Regeneron Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 71. Regeneron Recent Development
Table 72. Amgen Company Detail
Table 73. Amgen Business Overview
Table 74. Amgen Complement Drug Product
Table 75. Amgen Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 76. Amgen Recent Development
Table 77. Alnylam Company Detail
Table 78. Alnylam Business Overview
Table 79. Alnylam Complement Drug Product
Table 80. Alnylam Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 81. Alnylam Recent Development
Table 82. UCB Company Detail
Table 83. UCB Business Overview
Table 84. UCB Complement Drug Product
Table 85. UCB Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 86. UCB Recent Development
Table 87. InflaRx Company Detail
Table 88. InflaRx Business Overview
Table 89. InflaRx Complement Drug Product
Table 90. InflaRx Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 91. InflaRx Recent Development
Table 92. ChemoCentryx Company Detail
Table 93. ChemoCentryx Business Overview
Table 94. ChemoCentryx Complement DrugProduct
Table 95. ChemoCentryx Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 96. ChemoCentryx Recent Development
Table 97. Innate Pharma Company Detail
Table 98. Innate Pharma Business Overview
Table 99. Innate Pharma Complement DrugProduct
Table 100. Innate Pharma Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 101. Innate Pharma Recent Development
Table 102. Ionis Pharmaceuticals Company Detail
Table 103. Ionis Pharmaceuticals Business Overview
Table 104. Ionis Pharmaceuticals Complement DrugProduct
Table 105. Ionis Pharmaceuticals Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 106. Ionis Pharmaceuticals Recent Development
Table 107. Avant Immunotherapeutics Company Detail
Table 108. Avant Immunotherapeutics Business Overview
Table 109. Avant Immunotherapeutics Complement DrugProduct
Table 110. Avant Immunotherapeutics Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 111. Avant Immunotherapeutics Recent Development
Table 112. Pfizer Company Detail
Table 113. Pfizer Business Overview
Table 114. Pfizer Complement DrugProduct
Table 115. Pfizer Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 116. Pfizer Recent Development
Table 117. Sanofi Company Detail
Table 118. Sanofi Business Overview
Table 119. Sanofi Complement DrugProduct
Table 120. Sanofi Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 121. Sanofi Recent Development
Table 122. Omeros Company Detail
Table 123. Omeros Business Overview
Table 124. Omeros Complement DrugProduct
Table 125. Omeros Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 126. Omeros Recent Development
Table 127. GenMab Company Detail
Table 128. GenMab Business Overview
Table 129. GenMab Complement DrugProduct
Table 130. GenMab Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 131. GenMab Recent Development
Table 132. Akari Therapeutics Company Detail
Table 133. Akari Therapeutics Business Overview
Table 134. Akari Therapeutics Complement DrugProduct
Table 135. Akari Therapeutics Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 136. Akari Therapeutics Recent Development
Table 137. AbbVie Company Detail
Table 138. AbbVie Business Overview
Table 139. AbbVie Complement DrugProduct
Table 140. AbbVie Revenue in Complement Drug Business (2017-2022) & (US$ Million)
Table 141. AbbVie Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Complement Drug Market Share by Type: 2021 VS 2028
Figure 2. Peptides Features
Figure 3. Antibodies Features
Figure 4. Others Features
Figure 5. Global Complement Drug Market Share by Application in 2021 & 2028
Figure 6. Blood Disease Case Studies
Figure 7. Kidney Disease Case Studies
Figure 8. Others Case Studies
Figure 9. Complement Drug Report Years Considered
Figure 10. Global Complement Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Complement Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Complement Drug Market Share by Region: 2021 VS 2028
Figure 13. Global Complement Drug Market Share by Players in 2021
Figure 14. Global Top Complement Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Complement Drug Revenue in 2021
Figure 16. North America Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Complement Drug Market Share by Country (2017-2028)
Figure 18. United States Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Complement Drug Market Share by Country (2017-2028)
Figure 22. Germany Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Complement Drug Market Share by Region (2017-2028)
Figure 30. China Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Complement Drug Market Share by Country (2017-2028)
Figure 38. Mexico Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Complement Drug Market Share by Country (2017-2028)
Figure 42. Turkey Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Complement Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Novartis AG Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 45. Alexion Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 46. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 47. Roche Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 48. Apellis Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 49. Regeneron Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 50. Amgen Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 51. Alnylam Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 52. UCB Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 53. InflaRx Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 54. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 55. Innate Pharma Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 56. Ionis Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 57. Avant Immunotherapeutics Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 58. Pfizer Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 59. Sanofi Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 60. Omeros Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 61. GenMab Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 62. Akari Therapeutics Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 63. AbbVie Revenue Growth Rate in Complement Drug Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock